To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05609942
Title Study of Elenestinib (BLU-263) in Advanced Systemic Mastocytosis (AdvSM) and and Other KIT Altered Hematologic Malignancies (AZURE)
Acronym AZURE
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Blueprint Medicines Corporation
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NOR | NLD | FRA | ESP | DEU | BEL

Facility Status City State Zip Country Details
Stanford Cancer Institute Palo Alto California 94305 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
Antwerp University Hospital Edegem 2650 Belgium Details
University Hospital Ghent Ghent 9000 Belgium Details
CHU Caen - Institut d'Hematologie de Basse Normandie Caen 14033 France Details
University Medical Centre Mannheim Mannheim 68167 Germany Details
Maastricht University Medical Center Maastricht 6229 HX Netherlands Details
Oslo University Hospital Oslo 0450 Norway Details
Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast) Toledo 45071 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field